Results of NRG oncology/RTOG 9813: A phase III randomized study of radiation therapy (RT) and temozolomide (TMZ) versus RT and nitrosourea (NU) therapy for anaplastic astrocytoma (AA) Other Scholarly Work

Chang, Susan Marina, Zhang, Peixin, Cairncross, J Gregory et al. (2015). Results of NRG oncology/RTOG 9813: A phase III randomized study of radiation therapy (RT) and temozolomide (TMZ) versus RT and nitrosourea (NU) therapy for anaplastic astrocytoma (AA) . JOURNAL OF CLINICAL ONCOLOGY, 33(15), 10.1200/jco.2015.33.15_suppl.2002

International Collaboration

cited authors

  • Chang, Susan Marina; Zhang, Peixin; Cairncross, J Gregory; Gilbert, Mark R; Bahary, Jean-Paul; Dolinskas, Carol; Aldape, Kenneth D; Chakravarti, Arnab; Schiff, David; Jaeckle, Kurt A; Brown, Paul D; Barger, Geoffrey; Werner-Wasik, Maria; Shih, Helen Alice; Brachman, David; Penas-Prado, Marta; Robins, H Ian; Belanger, Karl; Schultz, Christopher J; Mehta, Minesh P

authors

publication date

  • May 20, 2015

webpage

published in

keywords

  • Life Sciences & Biomedicine
  • Oncology
  • Science & Technology

Location

  • Chicago, IL

Digital Object Identifier (DOI)

publisher

  • AMER SOC CLINICAL ONCOLOGY

volume

  • 33

issue

  • 15